Literature DB >> 19140113

Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.

Peter B Gilbert1, Li Qin, Steven G Self.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140113      PMCID: PMC4510047          DOI: 10.1002/sim.3503

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  Evaluating candidate principal surrogate endpoints.

Authors:  Peter B Gilbert; Michael G Hudgens
Journal:  Biometrics       Date:  2008-03-24       Impact factor: 2.571

2.  A framework for assessing immunological correlates of protection in vaccine trials.

Authors:  Li Qin; Peter B Gilbert; Lawrence Corey; M Juliana McElrath; Steven G Self
Journal:  J Infect Dis       Date:  2007-10-02       Impact factor: 5.226

3.  Correlates, surrogates, and vaccines.

Authors:  Jerald C Sadoff; Janet Wittes
Journal:  J Infect Dis       Date:  2007-10-02       Impact factor: 5.226

  3 in total
  3 in total

1.  Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.

Authors:  Peter B Gilbert; Michael G Hudgens; Julian Wolfson
Journal:  Int J Biostat       Date:  2011-09-20       Impact factor: 0.968

2.  Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.

Authors:  Anna S C Conlon; Jeremy M G Taylor; Michael R Elliott
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

3.  Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.

Authors:  Morgane Rolland; Peter Gilbert
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-27       Impact factor: 2.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.